Oncology: Prostate

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Augue lacus viverra vitae congue. Consequat mauris nunc congue nisi vitae. Ut consequat semper viverra nam. Vulputate eu scelerisque felis imperdiet.

This set of activities will focus on prostate cancer. 

Target Audience

  • Advanced practice providers

Learning Objectives

After participating in this activity, the learner will be able to:

  1. Identify male populations for whom providers should engage in shared decision-making regarding PSA screening, consistent with AUA guidelines.
  2. Discuss the risks and benefits of PSA screening in shared decision-making discussions with patients.
  3. Describe the commonest treatment options, including benefits and risks, for treatment of localized prostate cancer.
  4. Identify the commonest prostate cancer treatment-related side effects and possible management strategies to address these side effects.
  5. Define the specific time points and diagnostic tests for cancer surveillance of men treated for clinically localized prostate cancer.
  6. Define the time points and diagnostic tests used in the active surveillance of men with lower risk clinically localized prostate cancer.
  7. Describe the role of the urology provider in the management of advanced prostate cancer.
  8. Apply the AUA guidelines for the management of metastatic castrate-resistant prostate cancer.
Course summary
Course opens: 
02/20/2019
Course expires: 
02/20/2022
Parent activity set: 
Rating: 
0

NOTE: This activity is a non-CME resource. CME is not awarded for this activity. 

Available Credit

Accreditation Period

Course opens: 
02/20/2019
Course expires: 
02/20/2022
Please login or register to take this course.

To continue with this activity, please click on the TAKE COURSE button above.